Member access

4-Traders Homepage  >  Shares  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

Delayed Quote. Delayed TEL AVIV STOCK EXCHANGE - 11/27 10:24:20 am
22160 ILa   +0.54%
2d agoDJPHILLIP FROST : Teva Appoints Yitzhak Peterburg as Chairman
2d agoDJTEVA PHARMACEUTICAL : Correction to Teva Chairman Article
2d agoDJTEVA PHARMACEUTICAL : Appoints Yitzhak Peterburg as Chairman
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

Illumina: Teva Pharmaceutical Exclusive Distributor of Verifi Test in Israel

07/01/2013 | 07:27am US/Eastern
   By Melodie Warner 
 

Illumina Inc. (>> Illumina, Inc.) said Teva Pharmaceutical Industries Ltd. (>> Teva Pharmaceutical Industries Ltd (ADR)) will be the exclusive distributor of the verifi prenatal test in Israel under a five-year agreement.

Financial terms weren't disclosed.

Illumina paid $350 million in February to buy Verinata Health Inc., which gave it access to Verinata's verifi prenatal test, the broadest non-invasive prenatal test currently available for high-risk pregnancies.

The company said the MOR Institute for Medical Data Ltd., through its relationship with Teva, will provide the verifi test to customers of Clalit Health Services who are at high risk of having a fetus with a chromosomal abnormality.

The MOR Institute will also establish a 9,000-patient clinical outcomes registry to collect performance data and will share the data with Verinata.

Illumina said the patient registry developed through this collaboration will be the largest and most extensive of its kind.

Illumina shares closed Friday at $74.84 and were inactive premarket. The stock is up 35% this year.

Write to Melodie Warner at melodie.warner@dowjones.com

Stocks mentioned in the article : Illumina, Inc., Teva Pharmaceutical Industries Ltd (ADR)
React to this article
Latest news on TEVA PHARMACEUTICAL INDUST
1d ago TEVA PHARMACEUTICAL : Former Cellcom, Clalit CEO Peterburg is surprise choice as..
2d ago TEVA PHARMACEUTICAL : Launches Liquid Formulation of TREANDA® bendamustine HCI I..
2d ago TEVA PHARMACEUTICALS : USA's Trademark Application for "QNASL DRY MIST" Filed
2d ago TEVA PHARMACEUTICALS : USA's Trademark Application for "MERIT MECHANISMS OF REST..
2d ago TEVA PHARMACEUTICAL : An Application for the Trademark "MERIT MECHANISMS OF RESI..
2d ago TEVA PHARMACEUTICAL : An Application for the Trademark "REDIHALER" Has Been File..
2d ago TEVA PHARMACEUTICAL : Trademark Application for "PROAIR HFA (ALBUTEROL SULFATE I..
2d ago TEVA PHARMACEUTICAL : Trademark Application for "TREANDA" Filed by Teva Pharmace..
2d ago TEVA PHARMACEUTICAL : Patent Issued for Processes for Coating a Carrier with Mic..
2d agoDJPHILLIP FROST : Teva Appoints Yitzhak Peterburg as Chairman
Advertisement
Chart
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF